TB Unit, Liverpool Heart and Chest Hospital, Thomas Drive, Liverpool, UK.
Respirology. 2010 May;15(4):623-8. doi: 10.1111/j.1440-1843.2010.01749.x. Epub 2010 Apr 7.
Both tuberculosis and bronchiectasis carry a significant burden worldwide in terms of morbidity and mortality, as well as financial, especially in the developing world. Epidemiological data for tuberculosis are now more readily available since the World Health Organisation declared it 'a global emergency' in 1993. The global prevalence of bronchiectasis, a recognized sequel of tuberculosis, is unknown, but is by no means insignificant. The pathophysiology of chronic airflow obstruction in both of these diseases is poorly understood, but it is associated with an accelerated rate of loss in pulmonary function. This article examines the global burden of tuberculosis and bronchiectasis, and focuses on the interrelation with chronic airflow obstruction.
无论是肺结核还是支气管扩张症，在发病率和死亡率方面，以及在财务方面（特别是在发展中国家），都给全世界带来了巨大的负担。自 1993 年世界卫生组织宣布肺结核为“全球紧急情况”以来，现在已经更容易获得有关肺结核的流行病学数据。支气管扩张症是肺结核的一种公认的后遗症，其全球患病率尚不清楚，但绝不容忽视。这两种疾病慢性气流阻塞的病理生理学知之甚少，但与肺功能丧失的加速率有关。本文探讨了肺结核和支气管扩张症的全球负担，并重点关注了它们与慢性气流阻塞的相互关系。
